Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy

IntroductionSkin vaccination using dissolving microneedle patch (MNP) technology for transdermal delivery is a promising vaccine delivery strategy to overcome the limitations of the existing vaccine administration strategies using syringes. To improve the traditional microneedle mold fabrication tec...

Full description

Bibliographic Details
Main Authors: Mi-Hyun Lee, Hyejun Seo, Moon-Su Lee, Byoung Jun Kim, Hye Lin Kim, Du Hyung Lee, Jaehun Oh, Ju Yeop Shin, Ju Young Jin, Do Hyeon Jeong, Bum-Joon Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1178688/full
_version_ 1797802675154190336
author Mi-Hyun Lee
Mi-Hyun Lee
Mi-Hyun Lee
Hyejun Seo
Hyejun Seo
Hyejun Seo
Moon-Su Lee
Byoung Jun Kim
Hye Lin Kim
Hye Lin Kim
Du Hyung Lee
Du Hyung Lee
Jaehun Oh
Jaehun Oh
Jaehun Oh
Ju Yeop Shin
Ju Young Jin
Do Hyeon Jeong
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
author_facet Mi-Hyun Lee
Mi-Hyun Lee
Mi-Hyun Lee
Hyejun Seo
Hyejun Seo
Hyejun Seo
Moon-Su Lee
Byoung Jun Kim
Hye Lin Kim
Hye Lin Kim
Du Hyung Lee
Du Hyung Lee
Jaehun Oh
Jaehun Oh
Jaehun Oh
Ju Yeop Shin
Ju Young Jin
Do Hyeon Jeong
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
author_sort Mi-Hyun Lee
collection DOAJ
description IntroductionSkin vaccination using dissolving microneedle patch (MNP) technology for transdermal delivery is a promising vaccine delivery strategy to overcome the limitations of the existing vaccine administration strategies using syringes. To improve the traditional microneedle mold fabrication technique, we introduced droplet extension (DEN) to reduce drug loss. Tuberculosis remains a major public health problem worldwide, and BCG revaccination had failed to increase the protective efficacy against tuberculosis. We developed an MNP with live Mycobacterium paragordonae (Mpg) (Mpg-MNP) as a candidate of tuberculosis booster vaccine in a heterologous prime-boost strategy to increase the BCG vaccine efficacy.Materials and methodsThe MNPs were fabricated by the DEN method on a polyvinyl alcohol mask film and hydrocolloid-adhesive sheet with microneedles composed of a mixture of mycobacteria and hyaluronic acid. We assessed the transdermal delivery efficiency by comparing the activation of the dermal immune system with that of subcutaneous injection. A BCG prime Mpg-MNP boost regimen was administered to a mouse model to evaluate the protective efficacy against M. tuberculosis.ResultsWe demonstrated the successful transdermal delivery achieved by Mpg-MNP compared with that observed with BCG-MNP or subcutaneous vaccination via an increased abundance of MHCII-expressing Langerin+ cells within the dermis that could migrate into draining lymph nodes to induce T-cell activation. In a BCG prime-boost regimen, Mpg-MNP was more protective than BCG-only immunization or BCG-MNP boost, resulting in a lower bacterial burden in the lungs of mice infected with virulent M. tuberculosis. Mpg-MNP-boosted mice showed higher serum levels of IgG than BCG-MNP-boosted mice. Furthermore, Ag85B-specific T-cells were activated after BCG priming and Mpg-MNP boost, indicating increased production of Th1-related cytokines in response to M. tuberculosis challenge, which is correlated with enhanced protective efficacy.DiscussionThe MNP fabricated by the DEN method maintained the viability of Mpg and achieved effective release in the dermis. Our data demonstrate a potential application of Mpg-MNP as a booster vaccine to enhance the efficacy of BCG vaccination against M. tuberculosis. This study produced the first MNP loaded with nontuberculous mycobacteria (NTM) to be used as a heterologous booster vaccine with verified protective efficacy against M. tuberculosis.
first_indexed 2024-03-13T05:09:17Z
format Article
id doaj.art-c8fc58c68b174757943d1fc3be4df90e
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-13T05:09:17Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c8fc58c68b174757943d1fc3be4df90e2023-06-16T05:42:58ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-06-011410.3389/fimmu.2023.11786881178688Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategyMi-Hyun Lee0Mi-Hyun Lee1Mi-Hyun Lee2Hyejun Seo3Hyejun Seo4Hyejun Seo5Moon-Su Lee6Byoung Jun Kim7Hye Lin Kim8Hye Lin Kim9Du Hyung Lee10Du Hyung Lee11Jaehun Oh12Jaehun Oh13Jaehun Oh14Ju Yeop Shin15Ju Young Jin16Do Hyeon Jeong17Bum-Joon Kim18Bum-Joon Kim19Bum-Joon Kim20Bum-Joon Kim21Bum-Joon Kim22Bum-Joon Kim23Department of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of KoreaBK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaCancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of KoreaInstitute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of KoreaMedical Business Division, Raphas Co., Ltd., Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaCancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaCancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of KoreaBK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of KoreaMedical Business Division, Raphas Co., Ltd., Seoul, Republic of KoreaMedical Business Division, Raphas Co., Ltd., Seoul, Republic of KoreaMedical Business Division, Raphas Co., Ltd., Seoul, Republic of KoreaDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Republic of KoreaDepartment of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of KoreaBK21 FOUR Biomedical Science Project, Seoul National University College of Medicine, Seoul, Republic of KoreaCancer Research Institute, College of Medicine, Seoul National University, Seoul, Republic of KoreaInstitute of Endemic Diseases, Seoul National University Medical Research Center (SNUMRC), Seoul, Republic of KoreaLiver Research Institute, College of Medicine, Seoul National University, Seoul, Republic of KoreaIntroductionSkin vaccination using dissolving microneedle patch (MNP) technology for transdermal delivery is a promising vaccine delivery strategy to overcome the limitations of the existing vaccine administration strategies using syringes. To improve the traditional microneedle mold fabrication technique, we introduced droplet extension (DEN) to reduce drug loss. Tuberculosis remains a major public health problem worldwide, and BCG revaccination had failed to increase the protective efficacy against tuberculosis. We developed an MNP with live Mycobacterium paragordonae (Mpg) (Mpg-MNP) as a candidate of tuberculosis booster vaccine in a heterologous prime-boost strategy to increase the BCG vaccine efficacy.Materials and methodsThe MNPs were fabricated by the DEN method on a polyvinyl alcohol mask film and hydrocolloid-adhesive sheet with microneedles composed of a mixture of mycobacteria and hyaluronic acid. We assessed the transdermal delivery efficiency by comparing the activation of the dermal immune system with that of subcutaneous injection. A BCG prime Mpg-MNP boost regimen was administered to a mouse model to evaluate the protective efficacy against M. tuberculosis.ResultsWe demonstrated the successful transdermal delivery achieved by Mpg-MNP compared with that observed with BCG-MNP or subcutaneous vaccination via an increased abundance of MHCII-expressing Langerin+ cells within the dermis that could migrate into draining lymph nodes to induce T-cell activation. In a BCG prime-boost regimen, Mpg-MNP was more protective than BCG-only immunization or BCG-MNP boost, resulting in a lower bacterial burden in the lungs of mice infected with virulent M. tuberculosis. Mpg-MNP-boosted mice showed higher serum levels of IgG than BCG-MNP-boosted mice. Furthermore, Ag85B-specific T-cells were activated after BCG priming and Mpg-MNP boost, indicating increased production of Th1-related cytokines in response to M. tuberculosis challenge, which is correlated with enhanced protective efficacy.DiscussionThe MNP fabricated by the DEN method maintained the viability of Mpg and achieved effective release in the dermis. Our data demonstrate a potential application of Mpg-MNP as a booster vaccine to enhance the efficacy of BCG vaccination against M. tuberculosis. This study produced the first MNP loaded with nontuberculous mycobacteria (NTM) to be used as a heterologous booster vaccine with verified protective efficacy against M. tuberculosis.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1178688/fullMycobacterium tuberculosisMycobacterium paragordonaemicroneedle patchBCG booster vaccinedroplet extension method
spellingShingle Mi-Hyun Lee
Mi-Hyun Lee
Mi-Hyun Lee
Hyejun Seo
Hyejun Seo
Hyejun Seo
Moon-Su Lee
Byoung Jun Kim
Hye Lin Kim
Hye Lin Kim
Du Hyung Lee
Du Hyung Lee
Jaehun Oh
Jaehun Oh
Jaehun Oh
Ju Yeop Shin
Ju Young Jin
Do Hyeon Jeong
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Bum-Joon Kim
Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
Frontiers in Immunology
Mycobacterium tuberculosis
Mycobacterium paragordonae
microneedle patch
BCG booster vaccine
droplet extension method
title Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
title_full Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
title_fullStr Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
title_full_unstemmed Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
title_short Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
title_sort protection against tuberculosis achieved by dissolving microneedle patches loaded with live mycobacterium paragordonae in a bcg prime boost strategy
topic Mycobacterium tuberculosis
Mycobacterium paragordonae
microneedle patch
BCG booster vaccine
droplet extension method
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1178688/full
work_keys_str_mv AT mihyunlee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT mihyunlee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT mihyunlee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT hyejunseo protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT hyejunseo protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT hyejunseo protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT moonsulee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT byoungjunkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT hyelinkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT hyelinkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT duhyunglee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT duhyunglee protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT jaehunoh protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT jaehunoh protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT jaehunoh protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT juyeopshin protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT juyoungjin protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT dohyeonjeong protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy
AT bumjoonkim protectionagainsttuberculosisachievedbydissolvingmicroneedlepatchesloadedwithlivemycobacteriumparagordonaeinabcgprimebooststrategy